Autres langues KALA BIO, Inc. Börse Stuttgart

Actions

27F0

US4831192020

Marché Fermé - Börse Stuttgart Autres places de cotation 08:03:47 05/07/2024			Après clotûre 22:00:01
5,97 ^EUR	-0,33%		6,365	+6,62%

27/06	Les plus fortes hausses de la mi-journée	MT
27/06	Mise à jour sectorielle : Les actions du secteur de la santé sont mixtes en pré-marché jeudi	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

KALA BIO, Inc. announced that it has received $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP	28/06
Top Midday Gainers	27/06
Sector Update: Health Care Stocks Mixed Premarket Thursday	27/06
Kala Bio to Raise $12.5 Million in Private Placement; Shares Jump	27/06
KALA BIO Announces $12,500,000 Private Placement	27/06
KALA BIO, Inc. announced that it expects to receive $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP	26/06
KALA BIO : Corporate Overview - June 2024	05/06
KALA BIO to Present at Jefferies Global Healthcare Conference	29/05
KALA BIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update	14/05
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	01/04
KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
KALA BIO, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/03
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	29/03
KALA BIO, Inc. announced that it expects to receive $8.599799 million in funding from Baker Bros. Advisors LP	25/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
North American Morning Briefing : Inflation -2-	15/03
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference	26/02
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues KALA BIO, Inc. Börse Stuttgart

Actions

27F0

US4831192020

Autres langues

Filtres